Nephrol Dial Transplant (2002) 17: 1408-1412
© 2002 European Renal Association-European Dialysis and Transplant Association
PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients
Steno Diabetes Center, Gentofte, Denmark
Background. Recently, an amino acid variant (K121Q) in the glycoprotein PC-1 (Q allele) has been associated with faster progression of diabetic nephropathy, as estimated by calculated creatinine clearance. We tested the impact of the PC-1 (K121Q) variant on loss of glomerular filtration rate (GFR) measured by the [51Cr]EDTA plasma clearance technique.
Methods. We performed an observational follow-up study of 295 (182 males) type 1 patients with diabetic nephropathy [mean age 37 (SE 0.7) years, mean duration of diabetes 23 (SE 0.5) years]. All patients were followed for at least 3 years, median 8 years (range 3–17), with at least three measurements of GFR using [51Cr]EDTA (median 11 measurements (range 3–32)). Two hundred and seventeen patients had the KK genotype and 78 carried the Q allele (71 KQ and 7 QQ).
Results. Patients carrying the Q allele had a mean rate of decline in GFR during follow-up of 3.6 ml/min per year (SE 0.4) compared with 4.0 ml/min per year (SE 0.3) in patients with the KK genotype. Other risk factors for progression of diabetic nephropathy were similar in Q carriers and KK carriers. When dividing patients in tertiles based on rate of decline in GFR, we found no difference in distribution of K121Q genotypes. No difference in the number of patients who died or reached end-stage renal disease during follow-up according to K121Q genotype were found. A multiple linear regression analysis revealed that albuminuria, mean arterial blood pressure, haemoglobin A1C and serum cholesterol during follow-up predicted a steeper decline in GFR [R2 (adjusted)=0.27], whereas the PC-1 genotype did not contribute.
Conclusions. Our study did not reveal an association between the PC-1 amino acid variant K121Q and progression of diabetic nephropathy.
Keywords: diabetic nephropathy; glomerular filtration rate; PC-1 gene; progression; type 1 diabetes
Correspondence and offprint requests to: Peter Jacobsen, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark. Email: pkjacobsen{at}dadlnet.dk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Jacobsen Preventing end stage renal disease in diabetic patients -- genetic aspect (part I) Journal of Renin-Angiotensin-Aldosterone System, March 1, 2005; 6(1): 1 - 14. [Abstract] [PDF]
|
|
|
|
 |
|
 S. De Cosmo, R. Trevisan, M. Dalla Vestra, M. Vedovato, A. Argiolas, A. Solini, A. Saller, F. Damone, A. Tiengo, V. Trischitta, et al. PC-1 Amino Acid Variant Q121 Is Associated With a Lower Glomerular Filtration Rate in Type 2 Diabetic Patients With Abnormal Albumin Excretion Rates Diabetes Care, October 1, 2003; 26(10): 2898 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marre A KQ121 variant in the PC-1 gene and diabetic nephropathy: discrepant results between North and South Europe Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1546 - 1547. [Full Text] [PDF]
|
|